53 results
8-K
EX-10.1
RGBP
Regen BioPharma, Inc.
13 Sep 24
Entry into a Material Definitive Agreement
2:12pm
, and the Investor agrees that it shall not, and that it will cause its affiliates not to, engage in any short sales of or hedging transactions with respect
424B3
RGBP
Regen BioPharma, Inc.
24 Apr 24
Prospectus supplement
1:28pm
of Convertible Notes for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging. ASC 815-15 requires that the conversion features … feature of the Note for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion feature
424B3
RGBP
Regen BioPharma, Inc.
19 Jan 24
Prospectus supplement
1:29pm
for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging. ASC 815-15 requires that the conversion features are bifurcated and separately … consideration under ASC 815-15 “Derivatives and Hedging” and determined that the embedded conversion feature should be classified as a liability due
424B3
4jf4amh
20 Nov 23
Prospectus supplement
9:38am
424B3
gc2qlf9p
2 Oct 23
Prospectus supplement
1:42pm
8-K
EX-10.1
bj9q603dd c3jz
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
424B3
96kjjr
15 May 23
Prospectus supplement
10:25am